Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 11/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 9/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 9/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 8/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 8/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 8/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 8/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 8/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.36 |
| ▸ | OTC | P00480 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34467689 | 0.90 | ALB (0.46) | ALBBCHEFOLH1HDAC6HDAC3 | |
| SCHEMBL34467663 | 0.89 | BCHE (0.40) | ALBBCHEASAH1FOLH1OTC | |
| SCHEMBL31300275 | 0.83 | DPP4 (0.38) | BCHEHDAC6HDAC3HDAC1HDAC2 | |
| SCHEMBL34467671 | 0.79 | L3MBTL1 (0.37) | ALBBCHEOTC | |
| SCHEMBL34467669 | 0.79 | HDAC3 (0.41) | BCHEHDAC6HDAC3HDAC1HDAC2 | |
| SCHEMBL34467679 | 0.79 | HDAC6 (0.38) | ASAH1FOLH1HDAC6HDAC3HDAC1 | |
| SCHEMBL30544867 | 0.77 | SCN9A (0.43) | FOLH1 | |
| SCHEMBL34467662 | 0.77 | OTC (0.36) | OTC | |
| SCHEMBL31300265 | 0.74 | P2RY14 (0.36) | HDAC6HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL31300250 | 0.72 | KMT2A (0.45) | BCHEHDAC6HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117274-A1 | ORTHOGONALLY CROSSLINKED PROTEINS, METHODS OF MAKING, AND USES THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2026-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117274-A1 | ORTHOGONALLY CROSSLINKED PROTEINS, METHODS OF MAKING, AND USES THEREOF | PTMS, PSMG3, PSMB3 | ALB 270/4885BCHE 1974/4885ASAH1 4541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.